In July 2022, the FDA earned approval for the new Prodisc C Nova, according to an Oct. 31 news release.
This is Centinel’s third new cervical TDR product released since late 2022. The Prodisc C Vivo and Prodisc C SK products were both introduced on a limited basis in late 2022 and have been used in over 8,000 procedures since.
Alex Sielatycki, MD, a surgeon at Steamboat Orthopedic & Spine Institute in Steamboat Springs, Colo., performed the first Prodisc C Nova procedure.
Prodisc C Nova was co-developed by spine surgeon Rudolf Bertagnoli, MD, in Straubing, Germany, and first implanted in Europe in 2009.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
